Statistics on Biotechnology Use  
Business Sector
Biotechnology indicators by relevance of biotechnology in the company's activity.
Unidades: Specified in each variable

,Total,Main,Secondary,Tool required,
Companies carrying out R&D in Biotechnology,1.444,629,262,553,
% Companies by type of biotechnology used: Genetic Code,30,7,39,9,25,7,22,5,
% Companies by type of biotechnology used: Functional Units,37,6,46,4,39,8,26,5,
% Companies by type of biotechnology used: Cell and Tissue Culture and Engineering,21,3,26,3,20,16,2,
% Companies by type of biotechnology used: Bioprocesses,50,9,42,3,57,58,
% Companies by type of biotechnology used: Subcellular Organisms,8,1,11,6,5,5,5,2,
% Companies by type of biotechnology used: Bioinformatics,22,6,32,3,21,12,5,
% Companies by type of biotechnology used: Nanobiotechnology,9,8,14,5,10,1,4,4,
% Companies by type of biotechnology used: Other,16,9,18,1,19,5,14,2,
% Companies by final application areas of biotechnology use: Human Health,44,3,65,33,6,25,9,
% Companies by final application areas of biotechnology use: Animal Health and Aquaculture,15,8,16,9,18,13,5,
% Companies by final application areas of biotechnology use: Food Products,30,7,24,8,30,6,37,5,
% Companies by final application areas of biotechnology use: Agriculture and Forestry,24,9,21,3,28,7,27,3,
% Companies by final application areas of biotechnology use: Environment,16,9,17,9,20,5,14,2,
% Companies by final application areas of biotechnology use: Industry,12,6,13,1,15,9,10,4,
R&D personnel in Biotechnology (PP),17.743,8.842,3.407,5.494,
R&D personnel in Biotechnology (PP): Research personnel,9.445,5.239,1.814,2.392,
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel,8.298,3.603,1.594,3.101,
R&D personnel in Biotechnology (PP). Women,9.907,5.154,1.970,2.782,
R&D personnel in Biotechnology (PP). Women: Research personnel,5.104,2.942,1.011,1.151,
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel,4.802,2.212,959,1.632,
R&D personnel in Biotechnology (FTE),12.993,4,7.060,1,2.147,6,3.785,7,
R&D personnel in Biotechnology (FTE): Research personnel,7.069,9,4.263,3,1.145,5,1.661,1,
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel,5.923,6,2.796,8,1.002,1,2.124,7,
R&D personnel in Biotechnology (FTE). Women,7.471,8,4.169,3,1.295,3,2.007,3,
R&D personnel in Biotechnology (FTE). Women: Research personnel,3.870,1,2.420,4,630,8,819,
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel,3.601,6,1.748,9,664,5,1.188,2,
Expenditure on internal R&D in Biotechnology (thousands of euros),1.223.801,670.507,216.401,336.893,
1) By type of expenditure: Current expenditure,1.108.189,604.206,191.555,312.429,
1.1) Labour expenditure of research personnel,360.922,207.759,64.211,88.953,
1.2) Labour expenditure of technical and auxiliary personnel,220.540,104.553,29.638,86.349,
1.3) Other current expenditure,526.727,291.895,97.706,137.126,
2) By type of expenditure: Capital expenditure,115.612,66.301,24.847,24.464,
2.1) Land and buildings,16.843,12.566,799,3.478,
2.2) Equipment and tools,63.527,33.190,12.906,17.431,
2.3) Acquisition of specific R&D software,3.959,2.511,548,900,
2.4) Other R&D-specific IP products,31.284,18.033,10.594,2.656,
1.1) By origin of funds: Own funds,860.603,442.509,148.111,269.983,
1.2) By origin of funds: Funds from the Business sector,128.002,86.860,21.937,19.205,
1.3) By origin of funds: Funds from the Public Administration sector,119.498,69.092,24.659,25.748,
1.4) By origin of funds: Funds from the Higher Education sector,647,620,0,28,
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector,12.986,9.058,0,3.927,
1.6) By origin of funds: Funds from the rest of the world,102.065,62.369,21.694,18.002,
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros),123.396,113.418,5.801,4.177,
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain,88.985,80.703,4.777,3.505,
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world,34.412,32.714,1.024,673,
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to capital,39,8,50,1,36,6,29,6,
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information,15,3,13,3,19,2,15,7,
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to human resources,22,3,24,21,2,20,9,
% Companies that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain,12,1,10,8,15,9,11,7,
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets,17,1,17,6,21,4,14,4,
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels,17,8,20,3,20,6,13,7,
% Companies that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception,16,17,9,18,2,12,8,
% Companies that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements,41,4,46,2,41,9,35,8,
% Companies that consider the following obstacles to the development of biotechnologies as very important: Time/cost,50,2,57,5,50,1,42,
% Companies that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting,20,1,21,8,22,6,17,
% Companies with international revenues related to biotechnology activities,22,7,30,6,21,8,14,2,
% Companies representing international revenues related to biotechnology activities,2,1,13,2,0,4,2,2,
% International revenues related to biotechnology activities distributed in: Revenues from the EU,60,6,62,9,52,4,59,7,
% International revenues related to biotechnology activities distributed in: Revenues from the rest of the world,39,4,37,1,47,6,40,3,
% International revenues related to biotechnology activities by classification: International trade in goods and services,87,8,79,4,98,99,1,
% International revenues related to biotechnology activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,10,1,17,6,0,0,
% International revenues related to biotechnology activities by classification: Subsidies from external sources,1,4,1,7,2,0,7,
% International revenues related to biotechnology activities by classification: Other,0,8,1,2,0,0,2,
Notas:
Data referring to all companies that carry out internal R&D in Biotechnology.
 2) ' .'= numeric data equal to zero not resulting from rounding
 3) FTE: Full-Time Equivalence
Fuente: National Statistics Institute